Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.

Moniepoint has secured an investment from Visa (V), a global leader in digital payments. The investment marks an important milestone in Visa’s ...

A $20 million Lilly Endowment grant aims to make Gary and ... The funding will launch NWI Thrive, a multi-faceted project that will include new trails, trail improvements, educational campaigns ...

Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity ...

Purdue partners with Eli Lilly and Merck to launch the Young Institute Pharmaceutical Manufacturing Consortium, focusing on sterile injectables.

We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are ...

City rental studios thrive on demand for outfits such as long-trail dresses and tuxedos used in pre-wedding & maternity shoots Stay in style: Kolkata warms up to luxury outfit rentals Many in the ...

Arianna Huffington's Thrive Global has a new partnership with Eli Lilly, sharing tips for healthy living where patients already fill their prescriptions.

Last year, Thrive Global teamed up with OpenAI to create Thrive AI Health, an AI-powered health coach trained on the company’s behavior-change research and customers’ self-reported health data to ...